Guardion Health Sciences, Inc. (GHSI) financial statements (2022 and earlier)

Company profile

Business Address 2925 RICHMOND AVENUE
HOUSTON, TX 77098
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,0908,51911,1166714,73563
Cash and cash equivalents4,0948,51911,1166714,73563
Short-term investments4,996     
Receivables1,412117828732
Inventory, net of allowances, customer advances and progress billings36838531135815544
Inventory36838531135815544
Prepaid expense 18036348  
Other current assets  44176  
Other undisclosed current assets1,200 (441)(76)11729
Total current assets:12,0699,09511,8681,1055,080138
Noncurrent Assets
Operating lease, right-of-use asset24419573
Property, plant and equipment11128637527596114
Intangible assets, net (including goodwill)11,25650502,0202,184 
Goodwill   1,5641,564 
Intangible assets, net (excluding goodwill)11,2565050456621 
Deposits noncurrent assets 1212   
Deferred costs   270  
Other noncurrent assets 121212  
Other undisclosed noncurrent assets (12)(12) 1010
Total noncurrent assets:11,3917661,0092,5762,290124
TOTAL ASSETS:23,4619,86112,8773,6817,370262
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,137736129414311356
Accounts payable241608    
Accrued liabilities895128    
Other undisclosed accounts payable and accrued liabilities  129414311356
Debt  152 3169
Deferred rent credit  11681
Derivative instruments and hedges, liabilities 2613   
Due to related parties 298  14691
Deferred revenue and credits1288
Other undisclosed current liabilities2214   3
Total current liabilities:1,1591,074410495500608
Noncurrent Liabilities
Long-term debt and lease obligation4272435   
Operating lease, liability4272435
Other undisclosed noncurrent liabilities(4)(272)    
Total noncurrent liabilities:4272435   
Total liabilities:1,1631,346845495500608
Stockholders' equity
Stockholders' equity attributable to parent, including:22,2988,51512,0323,1866,870346
Preferred stock     2
Common stock241575214025
Additional paid in capital101,07562,58357,46937,79933,69620,278
Accumulated deficit(78,802)(54,083)(45,512)(34,633)(26,866)(20,650)
Other undisclosed stockholders' equity attributable to parent     691
Other undisclosed stockholders' equity     (691)
Total stockholders' equity:22,2988,51512,0323,1866,870(346)
TOTAL LIABILITIES AND EQUITY:23,4619,86112,8773,6817,370262

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues7,2331,890903942437141
Revenue, net437141
Amortization of lease incentives  (148) 
Cost of revenue
(Cost of Goods and Services Sold)
(4,123)(1,947)(341)(398)(175)(76)
Gross profit:3,110(57)56254426265
Operating expenses(27,857)(8,495)(11,059)(6,688)(5,543)(4,011)
Operating loss:(24,747)(8,552)(10,497)(6,144)(5,281)(3,946)
Nonoperating income (expense)2(20)381(1,624)  
Interest and debt expense (7)(258)(2)(24)(1,803)
Net loss:(24,745)(8,579)(10,374)(7,770)(5,305)(5,748)
Other undisclosed net income (loss) attributable to parent 7(504)2  
Net loss attributable to parent:(24,745)(8,572)(10,878)(7,767)(5,305)(5,748)
Preferred stock dividends and other adjustments    (309)(35)
Other undisclosed net loss available to common stockholders, basic    (602)(760)
Net loss available to common stockholders, diluted:(24,745)(8,572)(10,878)(7,767)(6,216)(6,543)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(24,745)(8,579)(10,374)(7,770)(5,305)(5,748)
Comprehensive loss, net of tax, attributable to parent:(24,745)(8,579)(10,374)(7,770)(5,305)(5,748)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: